NO20003825D0 - 1,3,4 - oxadiazolonderivater - Google Patents
1,3,4 - oxadiazolonderivaterInfo
- Publication number
- NO20003825D0 NO20003825D0 NO20003825A NO20003825A NO20003825D0 NO 20003825 D0 NO20003825 D0 NO 20003825D0 NO 20003825 A NO20003825 A NO 20003825A NO 20003825 A NO20003825 A NO 20003825A NO 20003825 D0 NO20003825 D0 NO 20003825D0
- Authority
- NO
- Norway
- Prior art keywords
- oxadiazolone derivatives
- oxadiazolone
- derivatives
- Prior art date
Links
- WTSXVIMLKCKWIW-UHFFFAOYSA-N 3h-1,3,4-oxadiazol-2-one Chemical class O=C1NN=CO1 WTSXVIMLKCKWIW-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
- C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7296698P | 1998-01-29 | 1998-01-29 | |
| US10227498P | 1998-09-29 | 1998-09-29 | |
| PCT/US1999/000910 WO1999038510A1 (en) | 1998-01-29 | 1999-01-15 | Derivatives of 1,3,4-oxadiazolone |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20003825L NO20003825L (no) | 2000-07-26 |
| NO20003825D0 true NO20003825D0 (no) | 2000-07-26 |
| NO317102B1 NO317102B1 (no) | 2004-08-09 |
Family
ID=26753969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20003825A NO317102B1 (no) | 1998-01-29 | 2000-07-26 | 1,3,4 - oxadiazolonderivater |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6034113A (no) |
| EP (1) | EP1051173A4 (no) |
| JP (1) | JP2002527352A (no) |
| KR (1) | KR20010077838A (no) |
| CN (1) | CN1150175C (no) |
| AR (1) | AR010712A1 (no) |
| AU (1) | AU735704B2 (no) |
| BG (1) | BG104706A (no) |
| BR (1) | BR9913010A (no) |
| CA (1) | CA2318830A1 (no) |
| CO (1) | CO5090837A1 (no) |
| EE (1) | EE04089B1 (no) |
| GE (1) | GEP20032914B (no) |
| HU (1) | HUP0102025A3 (no) |
| ID (1) | ID26909A (no) |
| IL (1) | IL137518A0 (no) |
| LT (1) | LT4838B (no) |
| LV (1) | LV12559B (no) |
| NO (1) | NO317102B1 (no) |
| NZ (1) | NZ505409A (no) |
| PL (1) | PL342060A1 (no) |
| RU (1) | RU2202548C2 (no) |
| SK (1) | SK10852000A3 (no) |
| TR (1) | TR200002019T2 (no) |
| TW (1) | TW550075B (no) |
| UA (1) | UA58579C2 (no) |
| WO (1) | WO1999038510A1 (no) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003525199A (ja) * | 1998-01-29 | 2003-08-26 | ブリストル−マイヤーズ スクイブ カンパニー | ジアリール１，３，４−オキサジアゾロンアミノ酸誘導体 |
| WO2000044745A1 (en) * | 1999-01-29 | 2000-08-03 | Bristol-Myers Squibb Company | Carbamate derivatives of diaryl 1,3,4-oxadiazolone |
| US6297241B1 (en) | 1999-01-29 | 2001-10-02 | Bristol-Myers Squibb Company | Carbamate derivatives of diaryl 1,3,4-oxadiazolone |
| US6326388B1 (en) * | 1999-12-21 | 2001-12-04 | Celgene Corporation | Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level |
| CA2438868A1 (en) | 2001-02-20 | 2002-09-19 | Valentin K. Gribkoff | Modulators of kcnq potassium channels and use thereof in treating migraine and mechanistically related diseases |
| US7759373B2 (en) * | 2001-04-16 | 2010-07-20 | Mitsubishi Tanabe Pharma Corporation | Large conductance calcium-activated K channel opener |
| US6909027B1 (en) * | 2001-08-13 | 2005-06-21 | Perry Robins | Method of forming an in-situ film dressing and the composition of the film-forming material |
| US7119246B2 (en) * | 2002-06-25 | 2006-10-10 | Perry Robins | Method of treating acne |
| IN2014KN02583A (no) | 2012-01-18 | 2015-05-08 | Techfields Pharma Co Ltd | |
| JP5855599B2 (ja) * | 2013-04-30 | 2016-02-09 | テックフィールズ バイオケム カンパニー リミテッド | 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ |
| CN104710379B (zh) * | 2015-03-09 | 2017-01-18 | 华南理工大学 | 一种bms‑191011的合成方法 |
| JP6165816B2 (ja) * | 2015-10-01 | 2017-07-19 | テックフィールズ バイオケム カンパニー リミテッド | 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ |
| US10265300B2 (en) * | 2017-02-24 | 2019-04-23 | Ovid Therapeutics Inc. | Methods of treating seizure disorders |
| CN110987847B (zh) * | 2019-12-11 | 2021-02-19 | 苏州今蓝纳米科技有限公司 | 1,3,4-噁二唑衍生物在检测酸以及数据加密和储存中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH583213A5 (no) * | 1973-05-21 | 1976-12-31 | Ciba Geigy Ag | |
| IT1251488B (it) * | 1991-09-17 | 1995-05-15 | Mini Ricerca Scient Tecnolog | Ossa(tia)diazol- e triazol-oni(tioni) ad attivita' acaricida ed insetticida |
| US5234947A (en) * | 1991-11-07 | 1993-08-10 | New York University | Potassium channel activating compounds and methods of use thereof |
| US5547966A (en) * | 1993-10-07 | 1996-08-20 | Bristol-Myers Squibb Company | Aryl urea and related compounds |
| TW467902B (en) * | 1996-07-31 | 2001-12-11 | Bristol Myers Squibb Co | Diphenyl heterocycles as potassium channel modulators |
| JP2003525199A (ja) * | 1998-01-29 | 2003-08-26 | ブリストル−マイヤーズ スクイブ カンパニー | ジアリール１，３，４−オキサジアゾロンアミノ酸誘導体 |
-
1999
- 1999-01-15 JP JP2000529243A patent/JP2002527352A/ja active Pending
- 1999-01-15 RU RU2000122733/04A patent/RU2202548C2/ru not_active IP Right Cessation
- 1999-01-15 WO PCT/US1999/000910 patent/WO1999038510A1/en not_active Application Discontinuation
- 1999-01-15 GE GEAP19995472A patent/GEP20032914B/en unknown
- 1999-01-15 PL PL99342060A patent/PL342060A1/xx unknown
- 1999-01-15 HU HU0102025A patent/HUP0102025A3/hu unknown
- 1999-01-15 UA UA2000085059A patent/UA58579C2/uk unknown
- 1999-01-15 CN CNB998024112A patent/CN1150175C/zh not_active Expired - Fee Related
- 1999-01-15 SK SK1085-2000A patent/SK10852000A3/sk unknown
- 1999-01-15 US US09/232,033 patent/US6034113A/en not_active Expired - Fee Related
- 1999-01-15 EP EP99902290A patent/EP1051173A4/en not_active Withdrawn
- 1999-01-15 CA CA002318830A patent/CA2318830A1/en not_active Abandoned
- 1999-01-15 ID IDW20001421A patent/ID26909A/id unknown
- 1999-01-15 BR BR9913010-6A patent/BR9913010A/pt not_active IP Right Cessation
- 1999-01-15 IL IL13751899A patent/IL137518A0/xx unknown
- 1999-01-15 EE EEP200000447A patent/EE04089B1/xx not_active IP Right Cessation
- 1999-01-15 TR TR2000/02019T patent/TR200002019T2/xx unknown
- 1999-01-15 AU AU22308/99A patent/AU735704B2/en not_active Ceased
- 1999-01-15 KR KR1020007008227A patent/KR20010077838A/ko not_active Application Discontinuation
- 1999-01-15 NZ NZ505409A patent/NZ505409A/en unknown
- 1999-01-27 AR ARP990100312A patent/AR010712A1/es not_active Application Discontinuation
- 1999-01-27 TW TW088101231A patent/TW550075B/zh not_active IP Right Cessation
- 1999-01-28 CO CO99004746A patent/CO5090837A1/es unknown
-
2000
- 2000-07-14 LT LT2000068A patent/LT4838B/lt not_active IP Right Cessation
- 2000-07-26 NO NO20003825A patent/NO317102B1/no not_active IP Right Cessation
- 2000-08-03 LV LVP-00-103A patent/LV12559B/en unknown
- 2000-08-22 BG BG104706A patent/BG104706A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LV12559B (en) | 2001-04-20 |
| RU2202548C2 (ru) | 2003-04-20 |
| UA58579C2 (uk) | 2003-08-15 |
| NO317102B1 (no) | 2004-08-09 |
| CN1289249A (zh) | 2001-03-28 |
| EE04089B1 (et) | 2003-08-15 |
| KR20010077838A (ko) | 2001-08-20 |
| CN1150175C (zh) | 2004-05-19 |
| LT2000068A (en) | 2001-03-26 |
| TW550075B (en) | 2003-09-01 |
| AU2230899A (en) | 1999-08-16 |
| ID26909A (id) | 2001-02-15 |
| TR200002019T2 (tr) | 2000-11-21 |
| CO5090837A1 (es) | 2001-10-30 |
| PL342060A1 (en) | 2001-05-21 |
| LV12559A (en) | 2000-11-20 |
| HUP0102025A2 (hu) | 2001-11-28 |
| CA2318830A1 (en) | 1999-08-05 |
| EP1051173A1 (en) | 2000-11-15 |
| EE200000447A (et) | 2001-12-17 |
| US6034113A (en) | 2000-03-07 |
| BG104706A (en) | 2001-04-30 |
| NO20003825L (no) | 2000-07-26 |
| GEP20032914B (en) | 2003-03-25 |
| JP2002527352A (ja) | 2002-08-27 |
| LT4838B (lt) | 2001-08-27 |
| IL137518A0 (en) | 2001-07-24 |
| AU735704B2 (en) | 2001-07-12 |
| EP1051173A4 (en) | 2002-07-31 |
| AR010712A1 (es) | 2000-07-12 |
| NZ505409A (en) | 2003-08-29 |
| WO1999038510A1 (en) | 1999-08-05 |
| HUP0102025A3 (en) | 2002-01-28 |
| SK10852000A3 (sk) | 2002-02-05 |
| BR9913010A (pt) | 2001-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE435861T1 (de) | 12,13-cyclopropan-epothilonderivate | |
| ID29241A (id) | Turunan-turunan kinolin teranelasi-1,2 | |
| ATE340176T1 (de) | Substituierte 6,5-heterobicyclische-derivate | |
| DK0925298T3 (da) | Substituerede 6,6-heterobicykliske derivater | |
| DK1000048T3 (da) | Substituerede 1,2,3,4-tetrahydronapthalenderivater | |
| NO20010193L (no) | Tiobenzimidazol-derivater | |
| DK0930302T3 (da) | Benzosulfonderivater | |
| ATE259810T1 (de) | Phenyl-xanthinderivate | |
| NO20010514L (no) | Aminometylkarboksylsyre-derivater | |
| DE69718771D1 (de) | Substituierte 1,2,3,4-tetrahydronaphthalinderivate | |
| DK1140835T3 (da) | 3,3-biarylpiperidin- og 2,2-biarylmorpholon-derivater | |
| EE04089B1 (et) | 1,3,4-oksadiasolooni derivaadid | |
| DE60025958D1 (de) | 14,15-beta-methylen substituierte androgene | |
| DK1115716T3 (da) | 2-phenylpyran-4-on-derivater | |
| ATE233253T1 (de) | Chromanderivate | |
| DK1134219T3 (da) | Cucloalkylsubstituerede aminomethylpyrrolidinderivater | |
| DK1149106T3 (da) | 4,5-azolo-oxindoler | |
| DK1060183T3 (da) | 5-deoxycytidinderivater | |
| ID26368A (id) | Turunan-turunan 2 deoksi higromisin | |
| DE69722064D1 (de) | 1,25-Dihydroxy-16,22,23-trisdehydro-Cholecalciferol-Derivate | |
| DE59907635D1 (de) | Pyrazolyldioxothiochromanoyl-derivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |